Abeona Therapeutics Inc(ABEO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABEO Abeona Therapeutics Inc

盘前交易 05-28 04:17:23 EDT

5.69

+0.20

+3.64%

盘前5.86

+0.17+2.99%

04:00 EDT

最高5.81	最低5.51	成交量106.54万
今开5.51	昨收5.49	日振幅5.37%
总市值3.25亿	流通市值2.42亿	总股本5,705万
成交额607.45万	换手率2.50%	流通股本4,260万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABEO","market":"US","secType":"STK","nameCN":"Abeona Therapeutics Inc","latestPrice":5.69,"timestamp":1779912000000,"preClose":5.49,"halted":0,"volume":1065369,"hourTrading":{"tag":"盘前","latestPrice":5.86,"preClose":5.69,"latestTime":"04:00 EDT","volume":72,"amount":421.92,"timestamp":1779955224244,"change":0.17,"changeRate":0.029877,"amplitude":0},"delay":0,"changeRate":0.0364298724954463,"floatShares":42603300,"shares":57049023,"eps":0.914286,"marketStatus":"盘前交易","change":0.2,"latestTime":"05-28 04:17:23 EDT","open":5.51,"high":5.805,"low":5.51,"amount":6074465.991159599,"amplitude":0.053734,"askPrice":6.57,"askSize":100,"bidPrice":5.03,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.914286,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779975000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.69,"preHourTrading":{"tag":"盘前","latestPrice":5.86,"preClose":5.69,"latestTime":"04:00 EDT","volume":72,"amount":421.92,"timestamp":1779955224244,"change":0.17,"changeRate":0.029877,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.64,"preClose":5.69,"latestTime":"19:32 EDT","volume":25938,"amount":147520.8325,"timestamp":1779924753389,"change":-0.05,"changeRate":-0.008787,"amplitude":0.008787},"volumeRatio":1.137302,"impliedVol":1.0513,"impliedVolPercentile":0.432},"requestUrl":"/m/hq/s/ABEO","defaultTab":"news","newsList":[{"id":"1192338179","title":"Abeona Therapeutics 计划于2027年下半年提交新药临床试验申请并启动ABO-701首次人体研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1192338179","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192338179?lang=zh_cn&edition=full","pubTime":"2026-05-13 19:31","pubTimestamp":1778671913,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics Inc 宣布，其针对ABO-701的研究计划取得明确进展。该公司预期将在2027年下半年向监管机构提交新药临床试验（IND）申请，并随即启动该候选药物的首次人体临床研究。这一时间表标志着公司研发管线中这一重要项目进入了新的实质性阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142821545","title":"Abeona Therapeutics宣布费城儿童医院成为Zevaskyn®新认证治疗中心","url":"https://stock-news.laohu8.com/highlight/detail?id=1142821545","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142821545?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:35","pubTimestamp":1778502900,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics公司近日宣布，费城儿童医院已被激活，成为其基因疗法Zevaskyn®的新认证治疗中心。此举旨在扩大该创新疗法的可及性，为符合条件的患者提供专业治疗服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195372622","title":"Abeona Therapeutics 全年营运收入为-8944.8万美元，远逊于Ibes预估的-7840万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195372622","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195372622?lang=zh_cn&edition=full","pubTime":"2026-03-17 19:31","pubTimestamp":1773747071,"startTime":"0","endTime":"0","summary":"生物技术公司Abeona Therapeutics Inc公布的最新财务数据显示，其全年营运收入录得-8944.8万美元。这一表现显著低于市场研究机构Ibes此前预估的-7840万美元，凸显出公司在实现盈利方面仍面临挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127779905","title":"Abeona Therapeutics Inc：Zevaskyn 额外活检计划于本季度剩余时间进行","url":"https://stock-news.laohu8.com/highlight/detail?id=1127779905","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127779905?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:33","pubTimestamp":1773055992,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics Inc 宣布，针对其研究性疗法 Zevaskyn 的额外活检计划已安排在本季度剩余时间内完成。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108449306","title":"Abeona Therapeutics® 公布业务进展，Zevaskyn® 商业上市势头持续增强","url":"https://stock-news.laohu8.com/highlight/detail?id=1108449306","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108449306?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:31","pubTimestamp":1773055916,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics Inc 近期发布了业务更新，重点强调了其基因疗法 Zevaskyn® 在商业上市过程中不断积累的积极势头。公司表示，相关准备工作正在稳步推进，市场初步反馈良好，为后续的商业化成功奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517260910","title":"Abeona Therapeutics Inc.盘中异动 大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517260910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517260910?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185145,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Abeona Therapeutics Inc.股票出现异动，股价大幅拉升5.13%。截至发稿，该股报5.33美元/股，成交量6506股，换手率0.01%，振幅0.00%。Abeona Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为342.41%、257.25%、186.62%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Invivyd, Inc.，振幅分别为23.90%、13.51%、13.21%。Abeona Therapeutics Inc.公司简介：Abeona Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223225abe9b0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223225abe9b0fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABEOW","BK4139","ABEO","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517926917","title":"Abeona Therapeutics(ABEO.US)获奥本海默首次覆盖，给予优于大市评级, 目标价16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517926917","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517926917?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:04","pubTimestamp":1741183446,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics(ABEO.US)获奥本海默首次覆盖，给予优于大市评级, 目标价16.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05220448547630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ABEO","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506304699","title":"Abeona Therapeutics Inc.盘中异动 大幅拉升5.23%报5.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506304699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506304699?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:05","pubTimestamp":1737993938,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时05分，Abeona Therapeutics Inc.股票出现波动，股价大幅拉升5.23%。截至发稿，该股报5.54美元/股，成交量9.3329万股，换手率0.21%，振幅5.29%。Abeona Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为1969.92%、456.49%、218.44%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为86.84%、85.35%、65.16%。Abeona Therapeutics Inc.公司简介：Abeona Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280005389612481b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280005389612481b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ABEOW","ABEO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486087345","title":"Abeona Therapeutics Inc.盘中异动 股价大涨5.14%报6.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486087345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486087345?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:08","pubTimestamp":1732720109,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日23时08分，Abeona Therapeutics Inc.股票出现异动，股价快速拉升5.14%。截至发稿，该股报6.34美元/股，成交量7.1051万股，换手率0.16%，振幅4.89%。Abeona Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Abeona Therapeutics Inc.公司简介：Abeona Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127230830abe37c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127230830abe37c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABEOW","BK4139","ABEO","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2471638995","title":"Abeona Therapeutics Inc.盘中异动 大幅拉升5.26%报6.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471638995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471638995?lang=zh_cn&edition=full","pubTime":"2024-09-30 22:08","pubTimestamp":1727705304,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日22时08分，Abeona Therapeutics Inc.股票出现波动，股价大幅上涨5.26%。截至发稿，该股报6.20美元/股，成交量7.7815万股，换手率0.18%，振幅5.26%。Abeona Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Abeona Therapeutics Inc.公司简介：Abeona Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220824ab672922&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930220824ab672922&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABEOW","LENZ","BK4139","ABEO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abeonatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0695},{"period":"1month","weight":0.0655},{"period":"3month","weight":0.0942},{"period":"6month","weight":0.1223},{"period":"1year","weight":-0.0703},{"period":"ytd","weight":0.0797}],"compareEarnings":[{"period":"1week","weight":0.0124},{"period":"1month","weight":0.0493},{"period":"3month","weight":0.0887},{"period":"6month","weight":0.0981},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Abeona Therapeutics, Inc.于1974年在怀俄明州注册成立。该公司是一家处于商业阶段的生物制药公司，为危及生命的疾病开发细胞和基因疗法。2025年4月28日，美国食品药品监督管理局批准了ZEVASKYN（prademagene zamikeracel）基因修饰的细胞片，作为第一种也是唯一一种基于自体细胞的基因疗法，用于治疗成人和儿童RDEB患者的伤口，RDEB是一种严重且令人衰弱的遗传性皮肤病。RDEB无法治愈，ZEVASKYN是唯一一种经美国食品药品监督管理局批准的产品，可以一次性治疗RDEB伤口。ZEVASKYN被美国食品药品监督管理局授予孤儿药和罕见儿科疾病名称。","yearOnYearQuotes":[{"month":1,"riseRate":0.090909,"avgChangeRate":-0.103016},{"month":2,"riseRate":0.636364,"avgChangeRate":0.111579},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.009228},{"month":4,"riseRate":0.727273,"avgChangeRate":0.040154},{"month":5,"riseRate":0.545455,"avgChangeRate":-0.005722},{"month":6,"riseRate":0.3,"avgChangeRate":0.003162},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.015738},{"month":8,"riseRate":0.636364,"avgChangeRate":0.073309},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.009981},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.003904},{"month":11,"riseRate":0.454545,"avgChangeRate":0.087228},{"month":12,"riseRate":0.181818,"avgChangeRate":-0.137446}],"exchange":"NASDAQ","name":"Abeona Therapeutics Inc","nameEN":"Abeona Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abeona Therapeutics Inc(ABEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Abeona Therapeutics Inc(ABEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Abeona Therapeutics Inc,ABEO,Abeona Therapeutics Inc股票,Abeona Therapeutics Inc股票老虎,Abeona Therapeutics Inc股票老虎国际,Abeona Therapeutics Inc行情,Abeona Therapeutics Inc股票行情,Abeona Therapeutics Inc股价,Abeona Therapeutics Inc股市,Abeona Therapeutics Inc股票价格,Abeona Therapeutics Inc股票交易,Abeona Therapeutics Inc股票购买,Abeona Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abeona Therapeutics Inc(ABEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Abeona Therapeutics Inc(ABEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}